EUVIMEDEUVIMED entdecken
Open Access

Cumulative Incidence of Mortality Associated with Cardiovascular–Kidney–Metabolic (CKM) Syndrome

Sophie E Claudel iD, Insa M Schmidt iD, Sushrut S Waikar, Ashish Verma iD

Journal of the American Society of Nephrology · 2025-07 · 36 (7) · 1343-1351

DOI: 10.1681/asn.0000000637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 11.02.2025. Verfasst von Sophie E Claudel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Boston Medical Center, Boston, Massachusetts. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Cardiovascular–kidney–metabolic (CKM) syndrome stages 1–4 were associated with a graded risk of cardiovascular mortality in a nationally representative sample of US adults. Risk was similar between stages 0 and 1, suggesting that stage 1 represents a prime opportunity for prevention and risk mitigation. CKM staging is specific to cardiovascular mortality, given lack of a strong association with either noncardiovascular or cancer mortality.

Background

It is imperative to critically evaluate the prognostic implications of cardiovascular–kidney–metabolic (CKM) syndrome staging to inform clinical practice. The primary aims of this study were to define the risk of mortality associated with each CKM syndrome stage and to determine the corresponding restricted mean survival time over a 15-year period.

Methods

This was a longitudinal study of 50,678 community-dwelling US adults aged 20 years and older with baseline data for CKM stage determination participating in the 1999–2018 National Health and Nutrition Examination Survey. CKM stages were defined according to the American Heart Association presidential advisory. Fifteen-year adjusted cumulative incidences of cardiovascular mortality were calculated for each stage from confounder-adjusted survival curves using the G-formula.

Results

Over a median 9.5-year follow-up, 2564 participants experienced cardiovascular death. The 15-year adjusted cumulative incidences of cardiovascular mortality were stage 0, 5.5% (95% confidence interval [CI], 1.8 to 9.3); stage 1, 5.7% (95% CI, 3.2 to 8.2); stage 2, 7.9% (95% CI, 6.8 to 9.1); stage 3, 8.7% (95% CI, 6.7 to 10.8); and stage 4, 15.2% (95% CI, 13.6 to 16.8). The absolute risk difference between CKM stage 4 and stage 0 at 15 years was 9.6% (95% CI, 5.6 to 13.6). The survival difference between CKM stage 0 and stage 4 at 15 years was 8.1 (95% CI, 8.0 to 8.2) months.

Conclusions

Our findings reveal a graded risk of cardiovascular mortality associated with higher CKM syndrome stage.

Schlagwörter

Stichwörter der Autor:innen

CKDcardiovascular diseasediabetes mellitusepidemiology and outcomesmortality risk

Autor:innen und Institutionen

  • Department of Medicine, Boston Medical Center, Boston, Massachusetts.
  • Section of Nephrology, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts.

ORCID-Profile: Sophie E Claudel, Insa M Schmidt, Ashish Verma

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Claudel, S. E., Schmidt, I. M., Waikar, S. S., & Verma, A. (2025). Cumulative Incidence of Mortality Associated with Cardiovascular–Kidney–Metabolic (CKM) Syndrome. Journal of the American Society of Nephrology, 36(7), 1343-1351. https://doi.org/10.1681/asn.0000000637

Vancouver

Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative Incidence of Mortality Associated with Cardiovascular–Kidney–Metabolic (CKM) Syndrome. Journal of the American Society of Nephrology. 2025;36(7):1343-1351. doi:10.1681/asn.0000000637

BibTeX
@article{Claudel2025,
  author = {Claudel, Sophie E and Schmidt, Insa M and Waikar, Sushrut S and Verma, Ashish},
  title = {Cumulative Incidence of Mortality Associated with Cardiovascular–Kidney–Metabolic (CKM) Syndrome},
  journal = {Journal of the American Society of Nephrology},
  year = {2025},
  volume = {36},
  number = {7},
  pages = {1343--1351},
  doi = {10.1681/asn.0000000637}
}
Kostenlos starten →